(Q85178117)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Non-small cell lung cancer in stages I-IIIB: Long-term results of definitive radiotherapy with doses ≥ 80 Gy in standard fractionation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Karl Wurstbauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Hannes Weise

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Heinz Deutschmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Peter Kopp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Florian Merz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Michael Studnicka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

30 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

Strahlentherapie und Onkologie

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

551-557

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936459%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00066-010-2108-3

15 February 2020

exact match

0 references

cites work

Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer

1 reference

12 December 2020

Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience

1 reference

12 December 2020

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

12 December 2020

Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer

1 reference

12 December 2020

Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa

1 reference

12 December 2020

Quasi-IMAT study with conventional equipment to show high plan quality with a single gantry arc

1 reference

12 December 2020

Biological factors influencing optimum fractionation in radiation therapy

1 reference

12 December 2020

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

1 reference

12 December 2020

Helical tomotherapy. Experiences of the first 150 patients in Heidelberg

1 reference

12 December 2020

Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma

1 reference

12 December 2020

Target splitting in radiation therapy for lung cancer: further developments and exemplary treatment plans

1 reference

12 December 2020

Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma

1 reference

12 December 2020

Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial

1 reference

12 December 2020

Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation

1 reference

12 December 2020

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study

1 reference

12 December 2020

Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial

1 reference

12 December 2020

Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.

1 reference

12 December 2020

The International Epidemiology of Lung Cancer: geographical distribution and secular trends.

1 reference

12 December 2020

Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 S

1 reference

12 December 2020

Radiotherapy planning for lung cancer: slow CTs allow the drawing of tighter margins

1 reference

12 December 2020

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

1 reference

12 December 2020

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

1 reference

12 December 2020

Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-sm

1 reference

12 December 2020

Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy

1 reference

12 December 2020

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

12 December 2020

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Induction chemotherapy before chemoradiation in locally advanced non-small-cell lung cancer: failure after failure, again and again

1 reference

12 December 2020

Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.

1 reference

12 December 2020

"Augmented reality" in conventional simulation by projection of 3-D structures into 2-D images: a comparison with virtual methods.

1 reference

12 December 2020

Nonresected non-small-cell lung cancer in Stages I through IIIB: accelerated, twice-daily, high-dose radiotherapy--a prospective Phase I/II trial with long-term follow-up

1 reference

12 December 2020

A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients.

1 reference

12 December 2020

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology

1 reference

12 December 2020